Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by S. B. Rew
Generation of Potent Antitumor CTL From Patients With Multiple Myeloma Directed Against HM1.24
Clinical Cancer Research
Cancer Research
Oncology
Related publications
Sorafenib Has Potent Antitumor Activity Against Multiple Myeloma in Vitro, Ex Vivo, and in Vivo in the 5T33MM Mouse Model
Cancer Research
Cancer Research
Oncology
The Novel Immunotoxin HM1.24-ETA′ Induces Apoptosis in Multiple Myeloma Cells
Blood Cancer Journal
Oncology
Hematology
A Novel PI3K Inhibitor PIK-C98 Displays Potent Preclinical Activity Against Multiple Myeloma
Oncotarget
Oncology
Potent Antitumor Effect of Combination Therapy With Sub‑optimal Doses of Akt Inhibitors and Pomalidomide Plus Dexamethasone in Multiple Myeloma
Oncology Letters
Cancer Research
Oncology
Management of Older Patients With Multiple Myeloma
Blood Reviews
Oncology
Hematology
Prevalence of Apical Periodontitis in Patients With Multiple Myeloma
Medicina Oral, Patologia Oral y Cirugia Bucal
Medicine
Otorhinolaryngology
Surgery
Dentistry
Luliconazole Demonstrates Potent in Vitro Activity Against Dermatophytes Recovered From Patients With Onychomycosis
Journal of the American Academy of Dermatology
Dermatology
GPRC5D CAR T-Cell Therapy Has Antitumor Activity in Multiple Myeloma
Cancer Discovery
Oncology
Clinical Implications of C-Maf Expression in Plasma Cells From Patients With Multiple Myeloma
Experimental Hematology and Oncology
Cancer Research
Oncology
Hematology